Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Fewer metformin deaths

Metformin may be associated with a lower risk of death from cardiovascular disease, than other oral diabetic medicines, a US meta-analysis suggests.

than other oral diabetic medicines, a US meta-analysis suggests.

Analysis of 40 studies showed treatment with metformin was associated with a decreased risk of cardiovascular mortality (pooled OR, 0.74; 95% CI, 0.62-0.89) compared with any other oral diabetes agent or placebo.

The results for cardiovascular morbidity and all-cause mortality were similar but not statistically significant and no other significant associations of oral diabetes agents with fatal or nonfatal cardiovascular disease or all-cause mortality were observed.

Archives of Internal Medicine 2008; 168: 2070-80

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say